Upregulation of CIP2A in estrogen depletion‐resistant breast cancer cells treated with low‐dose everolimus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upregulation of CIP2A in estrogen depletion‐resistant breast cancer cells treated with low‐dose everolimus

Published:2020-09-03 Issue:10 Volume:10 Page:2072-2080
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Nishio Eiji¹,Hayashi Takanori²^ORCID,Akaza Mao²,Hisatomi Yukiko²,Hikichi Masahiro³,Fujii Takuma¹,Utsumi Toshiaki³,Harada Nobuhiro²,Shimono Yohei²

Affiliation:

1. Department of Obstetrics and Gynecology Fujita Health University School of Medicine Toyoake Japan

2. Department of Biochemistry Fujita Health University School of Medicine Toyoake Japan

3. Department of Breast Surgery Fujita Health University School of Medicine Toyoake Japan

Funder

Aichi Cancer Research Foundation

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.12956

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion

3. Estrogen receptor interaction with estrogen response elements

4. Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients

5. Advances in Adjuvant Endocrine Therapy for Postmenopausal Women

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer;Journal of Clinical Medicine;2022-03-14

2. Integrative assessment of CIP2A overexpression and mutational effects in human malignancies identifies possible deleterious variants;Computers in Biology and Medicine;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3